Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chimerix Inc (NQ: CMRX ) 0.9000 -0.0400 (-4.26%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chimerix Inc < Previous 1 2 3 4 5 Next > Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference September 03, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 30, 2024 From Chimerix, Inc. Via GlobeNewswire CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024 August 13, 2024 CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update August 13, 2024 From Chimerix, Inc. Via GlobeNewswire CMRX Stock Earnings: Chimerix Misses EPS for Q1 2024 May 01, 2024 CMRX stock results show that Chimerix missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Preview: Chimerix's Earnings February 28, 2024 Via Benzinga Earnings Outlook For Chimerix November 01, 2023 Via Benzinga Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market August 06, 2024 EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024 August 06, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2024 From Chimerix, Inc. Via GlobeNewswire 4 Analysts Have This to Say About Chimerix August 17, 2023 Via Benzinga Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market August 06, 2024 From FN Media Group LLC Via GlobeNewswire Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference May 30, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update May 01, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 April 24, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 16, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Appoints Marc D. Kozin to Board of Directors March 21, 2024 Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update February 29, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix to Present at TD Cowen 44th Annual Health Care Conference February 27, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 February 22, 2024 From Chimerix, Inc. Via GlobeNewswire Chimerix Appoints Lisa Decker to Board of Directors December 29, 2023 Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience From Chimerix, Inc. Via GlobeNewswire Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer December 04, 2023 Proven Leader Brings More Than 25 Years of Financial Experience From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) November 24, 2023 From Chimerix, Inc. Via GlobeNewswire Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer November 16, 2023 Seasoned Executive Brings More Than 25 Years of Industry Leadership Experience in Oncology Commercialization and Corporate Business Development From Chimerix, Inc. Via GlobeNewswire Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update November 02, 2023 From Chimerix, Inc. Via GlobeNewswire Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023 October 26, 2023 From Chimerix, Inc. Via GlobeNewswire NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying September 27, 2023 The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Overview Of Value Stocks In The Healthcare Sector September 18, 2023 Via Benzinga Chimerix to Participate in Upcoming Investor Conferences September 05, 2023 From Chimerix, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.